Online citations, reference lists, and bibliographies.
← Back to Search

Analysis Of The Risk Factors Associated With Endoscopic Sphincterotomy Techniques: Preliminary Results Of A Prospective Study, With Emphasis On The Reduced Risk Of Acute Pancreatitis With Low-dose Anticoagulation Treatment.

T. Rabenstein, H. Schneider, D. Bulling, M. Nicklas, A. Katalinic, E. Hahn, P. Martus, C. Ell
Published 2000 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND AND STUDY AIMS The aim of the present study was to analyze the risk factors associated with complications of endoscopic sphincterotomy (ES). PATIENTS AND METHODS In all consecutive endoscopic sphincterotomies carried out between September 1994 and December 1996, the possible risk factors (12 patient-related factors and 12 procedure-related ones), as well as the concomitant medical treatment, indications, techniques, and success of endoscopic sphincterotomy were evaluated prospectively. Risk factors were analyzed on an exploratory basis using univariate methods. "Potential risk factors" (univariate, P<0.1) underwent multivariate analysis to determine independent "risk factors" (multivariate, P<0.05). In addition, the complication rate was calculated according to the number of potential risk factors present. RESULTS A total of 438 patients who underwent ES were analyzed. Complications occurred in 7.5% (n = 33; acute pancreatitis 4.3%, hemorrhage 2.3 %, cholangitis 0.9%, technical 0.2%). Statistical analysis of the complications identified three independent risk factors (coagulopathy, patient age (< or =60 years, pancreas divisum), and one protective factor (pancreatic duct obstruction). The frequency of acute pancreatitis was increased by two independent risk factors (pancreas divisum, ES frequency <40 procedures/year) and was reduced if low-dose anticoagulation (unfractionated heparin or low molecular weight heparin) was administered (0.9%, one of 115 vs. 5.8%, 18 of 313; P<0.05). The effect of anticoagulation was not confounded by the presence or absence of other potential risk factors for acute pancreatitis. Neither the risk nor the severity of hemorrhage were increased by low-dose anticoagulation. Due to the low number of events, only potential risk factors for hemorrhage were identified (coagulopathy, intensive-care treatment). The overall complication rate and the incidence of pancreatitis and hemorrhage increased significantly depending on the number of simultaneous potential risk factors present (P<0.0001). CONCLUSIONS Patients at risk for complications after endoscopic sphincterotomy can be identified by risk factor analysis. These data suggest the hypothesis that low-dose anticoagulation prior to endoscopic sphincterotomy reduces the risk of acute pancreatitis after sphincterotomy.



This paper is referenced by
10.1007/s00464-007-9711-0
Severe and fatal complications after ERCP: Analysis of 2555 procedures in a single experienced center
P. Salminen (2007)
Risk Factors for Post-ERCP Pancreatitis: A Prospective
Chi-Liang Cheng (2006)
10.1007/s10620-019-05970-3
Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review
K. Johnson (2019)
10.3904/KJM.2015.89.5.487
The Endoscopic Management of Common Bile Duct Stones
Dong uk Kim (2015)
10.1007/s00535-017-1347-9
Factors associated with delayed hemorrhage after endoscopic sphincterotomy: Japanese large single-center experience
S. Ikarashi (2017)
10.2478/v10039-011-0012-4
Complications of endoscopic retrograde cholangiopancreatography (ERCP) and their risk factors.
M. Kostrzewska (2011)
10.3748/wjg.v20.i38.14033
Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis.
P. Cui (2014)
10.1016/S0016-5107(04)02169-8
Complications of ERCP: a prospective study.
M. Christensen (2004)
10.1155/2003/182398
Management of anticoagulants before and after endoscopy.
A. Hittelet (2003)
10.1055/a-1134-4873
Use of ERCP in the United States over the past decade
P. Kröner (2020)
10.3748/WJG.V10.I8.1212
Comparison of treatment outcomes between biliary plastic stent placements with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction.
P. Giorgio (2004)
10.1093/AGEING/AFI180
Endoscopic retrograde cholangiopancreatography in the elderly: a prospective and comparative study.
S. Köklü (2005)
ERCP PRo CEdu REs in a Finnish Community hos Pital: a REt Ros PECtiv E analysis o F 1207 Cas Es
Pekka Kuusanmäki (2012)
10.1111/den.13001
Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy
S. Ryozawa (2018)
Post-ERCP pancreatitis: patient and technique-related risk factors.
M. Freeman (2002)
10.4253/wjge.v9.i7.296
Assessment of the July effect in post-endoscopic retrograde cholangiopancreatography pancreatitis: Nationwide Inpatient Sample
Allison R. Schulman (2017)
10.1038/ajg.2010.136
Risk Factors for Post-ERCP Pancreatitis in High- and Low-Volume Centers and Among Expert and Non-Expert Operators: A Prospective Multicenter Study
P. Testoni (2010)
10.1067/MGE.2002.122616
Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?
T. Rabenstein (2002)
10.1016/J.CGH.2007.09.007
Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
M. Freeman (2007)
10.1016/j.gie.2008.11.022
Quality indicators, including complications, of ERCP in a community setting: a prospective study.
Joshua B Colton (2009)
10.1111/jgh.14604
Post‐endoscopic retrograde cholangiopancreatography pancreatitis in patients with asymptomatic common bile duct stones
H. Saito (2019)
Factores de riesgo predictores para complicaciones post-colangiopancreatografía retrógrada endoscópica
Alan Mijail Langarica Zárate (2016)
10.1111/j.1572-0241.2007.01544.x
A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
J. Dent (2008)
10.1016/j.mayocp.2016.10.028
The “Scope” of Post‐ERCP Pancreatitis
P. Parekh (2017)
10.17116/hirurgia2015835-40
[Methods of acute pancreatitis prevention after endoscopic transpapillary interventions].
A. G. Beburishvili (2015)
10.1067/MGE.2002.123622
ERCP outcomes: defining the operators, experience, and environments.
B. Petersen (2002)
10.1007/BF03023687
Ponction guidée par échoendoscopie: Résultats d’une étude monocentrique portant sur 1 323 patients
E. Bories (2009)
10.1007/s10620-006-9546-x
Early Decision for Precut Sphincterotomy: Is It a Risky Preference?
E. Parlak (2006)
10.1067/MGE.2003.307
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
S. Sherman (2003)
10.1016/S0016-5107(05)01572-5
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.
P. Mosler (2005)
10.1016/j.cgh.2008.11.020
Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Anthony T Debenedet (2009)
Acute pancreatitis – the most common complication after endoscopic retrograde cholangiopancreatography
Laura Maðalaitë (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar